RNAi-mediated inhibition of Rho kinase for treatment of ocular hypertension / glaucoma

Details for Australian Patent Application No. 2006330606 (hide)

Owner Alcon Manufacturing, Ltd.

Inventors Clark, Abbot F.; Chatterton, Jon E.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2006330606

PCT Pub. Number WO2007/076367

Priority 60/754,094 27.12.05 US

Filing date 19 December 2006

Wipo publication date 5 July 2007

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/7084 (2006.01) - Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide

Event Publications

26 June 2008 PCT application entered the National Phase

  PCT publication WO2007/076367 Priority application(s): WO2007/076367

3 July 2008 Alteration of Name

  The name of the applicant has been altered to Alcon Research, Ltd.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006330610-Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same

2006330602-Improved method for providing auxiliary power to an electric power plant using Fischer-Tropsch technology